270 results
Page 5 of 14
8-K
EX-99.1
x2g8zo2
1 Aug 12
Transgenomic Reports Second Quarter 2012 Financial Results
12:00am
8-K
EX-99.1
d5h5edqmp2ur3q
5 Nov 19
Precipio Announces Q3-2019 Corporate Update Call for Shareholders
4:00pm
8-K
EX-99.1
whs l2b5lcvjf3w
3 Oct 19
Precipio announces shareholder update call on commercial progress
12:00am
8-K
EX-99.1
tg1olyekjco0
14 Aug 19
Precipio Announces Q2-2019 Corporate Update Call for Shareholders
12:00am
8-K
EX-99.2
eg7irv2up9i
27 Feb 15
Transgenomic Announces Commencement of Public Offering of Common Stock
12:00am
8-K
EX-99.1
6wjkb4e66wi29mfut
19 Jul 00
Current report
12:00am
8-K
EX-4.1
zb1gj0wy9 aagxjuz
4 Jan 11
Transgenomic Announces Closing of the Acquisition of Clinical Data’s Diagnostic Business and the Closing of a $6 Million Financing
12:00am
8-K
EX-99.1
sylkck4
11 Aug 11
Transgenomic Reports Second Quarter Financial Results
12:00am
8-K
EX-99.1
is7hu 3hf4
16 Nov 18
Precipio Announces Third Quarter 2018 Corporate Update Call for Shareholders
4:47pm
8-K
EX-99.1
nar1ss
15 May 19
Other Events
4:08pm
8-K
EX-99.1
gyb1rubi
14 May 18
Growth resulting from commercial team reorganization, product and service cross-selling, and increased business stabilization
4:11pm
8-K
EX-99.1
wforvrhi is9
9 Aug 18
Precipio Appoints New Board Member to Replace Departing Director
4:31pm
8-K
EX-99.1
aa5snbja
14 Jan 20
Precipio announces shareholder update call to kick off 2020
2:24pm
8-K
EX-99.1
mab98fr
27 Feb 15
Transgenomic Announces Commencement of Public Offering of Common Stock
12:00am
8-K
EX-99.1
kzskik
18 Jul 18
Precipio Announces 213% Year-over-Year Revenue Growth in Preliminary Q2-2018 Results
4:50pm
8-K
EX-10.2
zcqroy
6 Mar 14
Transgenomic Announces $7 Million Convertible Preferred Stock Financing
12:00am
8-K
EX-99.1
2q6lbicjp
16 Mar 20
Precipio Completes the Transaction with Poplar Healthcare’s Oncometrix Hematopathology Division
4:17pm
8-K
EX-99.1
6rjbyg32
26 Apr 19
Amendments to Articles of Incorporation or Bylaws
11:01am